Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Vaccines01:30

Cancer Vaccines

616
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
616
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

634
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
634
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

249
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
249
Vaccinations01:51

Vaccinations

49.1K
Overview
49.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.

The Journal of infectious diseases·2026
Same author

Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice.

NPJ vaccines·2026
Same author

Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants.

Journal of virology·2026
Same author

Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques.

Immunity·2026
Same author

Maternal expression and breast milk transfer of an mRNA- encoded monoclonal antibody in a murine model of cholera.

PLoS neglected tropical diseases·2026
Same author

Harnessing mRNA for the expression of monoclonal IgG and IgA in non-human primates.

Frontiers in immunology·2026

相关实验视频

Updated: Nov 12, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K

疫苗开发的新方法

Makda S Gebre1, Luis A Brito2, Lisa H Tostanoski3

  • 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Cell
|March 19, 2021
PubMed
概括

像RNA和病毒载体平台这样的新型疫苗解决了对抗病原体的传统疫苗的局限性. 生物材料和工程技术的进步进一步加强了全球卫生安全的疫苗开发.

更多相关视频

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K

相关实验视频

Last Updated: Nov 12, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K

科学领域:

  • 疫苗学
  • 生物技术
  • 传染病研究

背景情况:

  • 传统疫苗至关重要,但面临着持久性,快速发展或新型病原体的挑战.
  • 现有的疫苗技术与复杂的抗原和新出现的传染病威胁作斗争.

研究的目的:

  • 审查新型疫苗技术的现状.
  • 突出RNA,病毒载体,生物材料和疫苗开发工程方面的进展.

主要方法:

  • 对核酸疫苗 (RNA) 的当前文献的审查.
  • 对病毒载体疫苗 (腺病毒) 的当前文献的综述.
  • 讨论与疫苗开发相关的生物材料和工程方面的进展.

主要成果:

  • 新型疫苗平台有望克服传统方法的局限性.
  • RNA和病毒载体疫苗非常适合挑战病原体.
  • 生物材料和工程提供了新的策略来提高疫苗的有效性和输送.

结论:

  • 新型疫苗技术在解决尚未满足的公共卫生需求方面取得了重大进展.
  • 对RNA,病毒载体,生物材料和工程的持续研究对于未来的疫苗创新至关重要.
  • 这些技术有可能彻底改变疫苗研发,改善全球健康状况.